Half-year report · HY
4572.TEDINET S100YV1G
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥401m | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥579m | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥251m | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | −¥954m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥1.8bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥1.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥920m | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | −¥408m | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥309m | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥517m | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥517m | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥915m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥995m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥605m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-53.13 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-113.62 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.29 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | -23.9% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Drug Discovery Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥67m |
| Drug Discovery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in notes and accounts payable trade ope cf | Prior1InterimDuration | -1694000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | InterimDuration | -254000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1InterimDuration | -21825000 | JPY |
| Increase decrease in accounts payable other ope cf | InterimDuration | -31111000 | JPY |
| Decrease increase in advance payments ope cf | Prior1InterimDuration | 37391000 | JPY |
| Decrease increase in advance payments ope cf | InterimDuration | -3222000 | JPY |
| Other net ope cf | Prior1InterimDuration | 34825000 | JPY |
| Other net ope cf | InterimDuration | 85900000 | JPY |
| Subtotal ope cf | Prior1InterimDuration | -995509000 | JPY |
| Subtotal ope cf | InterimDuration | -911678000 | JPY |
| Interest income received ope cf | Prior1InterimDuration | 4098000 | JPY |
| Interest income received ope cf | InterimDuration | 1913000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1InterimDuration | -887000 | JPY |
| Interest expenses paid ope cf fin cf | InterimDuration | -3010000 | JPY |
| Income taxes paid refund ope cf | Prior1InterimDuration | -2341000 | JPY |
| Income taxes paid refund ope cf | InterimDuration | -2150000 | JPY |
| Net cash provided by used in operating activities | Prior1InterimDuration | -994641000 | JPY |
| Net cash provided by used in operating activities | InterimDuration | -914926000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1InterimDuration | -140000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration | -4787000 | JPY |
| Expense by an increase in long term prepayment cost inv cf | Prior1InterimDuration | － | JPY |
| Expense by an increase in long term prepayment cost inv cf | InterimDuration | -5848000 | JPY |
| Purchase of investment securities inv cf | Prior1InterimDuration | -15743000 | JPY |
| Purchase of investment securities inv cf | InterimDuration | － | JPY |
| Other net inv cf | Prior1InterimDuration | － | JPY |
| Other net inv cf | InterimDuration | 41000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -15884000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -10593000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -9996000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -8410000 | JPY |
| Proceeds from issuance of bonds fin cf | Prior1InterimDuration | － | JPY |
| Proceeds from issuance of bonds fin cf | InterimDuration | 1711250000 | JPY |
| Redemption of convertible bonds fin cf | Prior1InterimDuration | － | JPY |
| Redemption of convertible bonds fin cf | InterimDuration | -250000000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1InterimDuration | － | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | InterimDuration | 31374000 | JPY |
| Proceeds from stock issuance to a third party fin cf | Prior1InterimDuration | － | JPY |
| Proceeds from stock issuance to a third party fin cf | InterimDuration | 19869000 | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | Prior1InterimDuration | － | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | InterimDuration | 3611000 | JPY |
| Other net fin cf | Prior1InterimDuration | -4010000 | JPY |
| Other net fin cf | InterimDuration | -4200000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -14006000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | 1503494000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -23384000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 5715000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -1047915000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 583689000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2108484000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 516789000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |